Bio-Rad Laboratories | BIO - Current Liabilities


Bio-Rad Laboratories reported $522.3M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Agilent USD 2.35B 455M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Bio Techne USD 144.54M 31.3M Sep/2025
Bio-Rad Laboratories USD 522.3M 26.6M Sep/2025
Bruker USD 1.27B 79.3M Sep/2025
Charles River Laboratories USD 1.12B 41.45M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Exact Sciences USD 584.26M 62.33M Sep/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Illumina USD 1.96B 501M Sep/2025
IQVIA Holdings USD 8.51B 936M Sep/2025
Laboratory Of America USD 2.63B 87.6M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Mettler Toledo International USD 1.19B 85.24M Sep/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Quest Diagnostics USD 2.13B 110M Sep/2025
Repligen USD 131.14M 8.12M Sep/2025
Revvity USD 1.22B 550.93M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Siemens EUR 47.26B 3.29B Sep/2025
Standard Biotools USD 107.96M 9.94M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Tosoh JPY 314.44B 22.76B Sep/2025
Waters USD 1.25B 235.17M Sep/2025